Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Bitfarms Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Bitfarms Q2 Earnings Call Highlights

Key Points

SpaceX Stock Posts Best Weekly Gain: Should You Tap It Via ETFs?
SpaceX Stock Posts Best Weekly Gain: Should You Tap It Via ETFs?

SpaceX SPCX closed a key week in the green, with shares climbing about 26%, after the company reported its first earnings as a public company and completed the largest share unlock in its brief

EFC Q2 Earnings Call Sees High-40s ADE as Longbridge Scales
EFC Q2 Earnings Call Sees High-40s ADE as Longbridge Scales

Ellington Financial Inc. EFC used its second-quarter earnings call to frame a higher earnings baseline, with management comfortable guiding adjusted distributable earnings into the high-40-cent

ARKO Q2 Earnings Call Centers on USPP Deal and Margin Defense: https://staticx-tuner.zacks.com/images/articles/main/30/172914.webp
ARKO Q2 Earnings Call Centers on USPP Deal and Margin Defense

ARKO Corp. ARKO entered its Q2 2026 call with a split message: retail demand softened as elevated fuel prices pressured consumers, but management kept full-year adjusted EBITDA guidance intact and

ACMR Q2 Earnings Call Raises Revenue Floor as Orders Accelerate
ACMR Q2 Earnings Call Raises Revenue Floor as Orders Accelerate

ACM Research, Inc. ACMR used its Q2 2026 call to emphasize stronger orders, new-product commercialization and firmer full-year visibility. First-half orders rose 105% year over year, with greater

Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?

Labcorp Holdings Inc. LH is entering the second half of 2026 with faster revenue growth, wider margins and higher full-year guidance. Specialty testing and Biopharma Laboratory Services are adding

SKWD Q2 Earnings Beat Estimates as Premium Growth AcceleratesPhoto, wide shot, wide-angle lens,  Reinsurance company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/490045fb-8676-41a9-be7a-bcf4281c7d92.png
SKWD Q2 Earnings Beat Estimates as Premium Growth Accelerates

Skyward Specialty Insurance Group, Inc. SKWD delivered a solid second quarter of 2026, with operating earnings per share of $1.30, which increased 46.1% from the year-ago level and beat the Zacks

FOXA Television and Tubi Drive Q4 Earnings as Cable Faces Higher Costs
FOXA Television and Tubi Drive Q4 Earnings as Cable Faces Higher Costs

Fox Corporation FOXA reported fourth-quarter fiscal 2026 adjusted earnings of $1.79 per share, which beat the Zacks Consensus Estimate of $1.34 by 33.58% and increased 41% year over year from

Can Altria's Smoke-Free Push Finally Drive Long-Term Growth?
Can Altria's Smoke-Free Push Finally Drive Long-Term Growth?

Altria Group, Inc.’s MO smoke-free strategy is increasingly centered on nicotine pouches, with on! PLUS emerging as a key part of that effort. In the second quarter of 2026, Helix expanded on! PLUS

Tripadvisor's Q2 Earnings and Revenues Miss Amid Macro Pressures
Tripadvisor's Q2 Earnings and Revenues Miss Amid Macro Pressures

Tripadvisor TRIP shares have appreciated 3.5% since the company reported its second quarter 2026 results on Aug. 6. The move comes even as both revenues and earnings missed the Zacks Consensus

AMC's Europe Business Roars Back: Can International Growth Continue?: https://staticx-tuner.zacks.com/images/articles/main/f8/4562.jpg
AMC's Europe Business Roars Back: Can International Growth Continue?

AMC Entertainment Holdings AMC delivered a standout second-quarter 2026 performance, with its European operations emerging as a key growth driver.

Attendance across Europe jumped 17.9% year over

Fiserv Cuts 2026 Outlook as Margin Pressure Tests Its Recovery Story
Fiserv Cuts 2026 Outlook as Margin Pressure Tests Its Recovery Story

Fiserv, Inc. FISV reset investor expectations after second-quarter 2026 earnings and revenues missed the Zacks Consensus Estimate and management lowered its full-year outlook. The central question

MPC Jumps 18.1% in 3 Months as Refining Strength Builds Momentum: https://staticx-tuner.zacks.com/images/articles/main/fe/157221.webp
MPC Jumps 18.1% in 3 Months as Refining Strength Builds Momentum

Marathon Petroleum Corporation MPC shares have gained 18.1% over the past three months, while the Zacks Consensus Estimate for current fiscal-year earnings has risen 41.6% in the past four weeks

Disney Beats on Parks & Streaming Growth in Q3: Buy or Hold the Stock?
Disney Beats on Parks & Streaming Growth in Q3: Buy or Hold the Stock?

Disney DIS delivered a third-quarter fiscal 2026 performance leaning on two durable engines, Experiences and streaming, even as shares have struggled to reflect that operating momentum. For the

Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months
Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months

Shares of Replimune Group REPL have surged nearly 223% over the past three months, as the company steadily advanced its lead oncolytic immunotherapy, RP1 (vusolimogene oderparepvec), toward

Eyeing Short-Term Opportunities? ETFs Worth a Look
Eyeing Short-Term Opportunities? ETFs Worth a Look

Market volatility is far from over, as investors continue to navigate shifting risks, ranging from bouts of rising geopolitical tensions stemming from the Middle East conflict to persistent weakness

Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?
Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?

Immunocore Holdings plc IMCR offers a clear trade-off between commercial momentum and valuation risk. Kimmtrak continues to expand in metastatic uveal melanoma, while late-stage studies could open

IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss

Immunocore Holdings plc IMCR posted second-quarter 2026 revenues of $115.9 million, up 18.3% year over year and above the Zacks Consensus Estimate of $114 million. The company’s loss of 2 cents per

Gates Industrial Raises 2026 Outlook as Industrial Demand StrengthensPhoto, wide shot, wide-angle lens,  Logistics company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a16a79c7-f73c-405d-ba63-e8d69b66ce4e.png
Gates Industrial Raises 2026 Outlook as Industrial Demand Strengthens

Gates Industrial Corporation Ltd. GTES raised its 2026 outlook after second-quarter 2026 results showed improving demand across a broad range of industrial markets. Higher core sales, improved

Is Gates Stock Worth Buying as Growth Improves but Risks Persist?Photo, wide shot, wide-angle lens,  Diversified industrial company, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/3bc2ecaa-ddda-4d9f-865e-4df253bbd22f.png
Is Gates Stock Worth Buying as Growth Improves but Risks Persist?

Gates Industrial Corporation Ltd. GTES entered the second half of 2026 with better operating momentum. The company's second-quarter core sales rose 4.9% year over year, and adjusted EBITDA margin